Franklin Resources’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77M | Buy |
|
|||||
|
2025
Q1 | $390K | Sell |
|
|||||
|
2024
Q4 | $4.57M | Buy |
|
|||||
|
2024
Q3 | $17.4M | Sell |
|
|||||
|
2024
Q2 | $18.3M | Sell |
|
|||||
|
2024
Q1 | $41.8M | Sell |
|
|||||
|
2023
Q4 | $27.8M | Buy |
|
|||||
|
2023
Q3 | $15.1M | Hold |
|
|||||
|
2023
Q2 | $19M | Hold |
|
|||||
|
2023
Q1 | $20.2M | Hold |
|
|||||
|
2022
Q4 | $22.7M | Sell |
|
|||||
|
2022
Q3 | $17.8M | Buy |
|
|||||
|
2022
Q2 | $13.1M | Buy |
|
|||||
|
2022
Q1 | $21.5M | Sell |
|
|||||
|
2021
Q4 | $23.1M | Buy |
|
|||||
|
2021
Q3 | $15.6M | Sell |
|
|||||
|
2021
Q2 | $16.8M | Buy |
|
|||||
|
2021
Q1 | $16M | Buy |
|
|||||
|
2020
Q4 | $18.3M | Buy |
|